Macfarlane, Gary J.Pathan, EjazJones, Gareth T.Dean, Linda E.2020-09-212020-09-212020-09Macfarlane, G J, Pathan, E, Jones, G T & Dean, L E 2020, 'Predicting response to anti-TNFα therapy among patients with axial spondyloarthritis (axSpA) : results from BSRBR-AS', Rheumatology, vol. 59, no. 9, pp. 2481-2490. https://doi.org/10.1093/rheumatology/kez6571462-0324ORCID: /0000-0003-2322-3314/work/75816019ORCID: /0000-0003-0016-7591/work/83703974https://hdl.handle.net/2164/15150We are grateful to the staff of the British Society for Rheumatology Biologics Register in Axial Spondyloarthritis register and to the recruiting staff at the clinical centres, details of which are available at: https://www.abdn.ac.uk/iahs/research/epidemiology/spondyloarthritis.php#panel1011. We are grateful to Jonathan Lock for commenting on the manuscript. Funding: This work was supported by the British Society for Rheumatology (BSR) who have funded the BSRBR-AS. The BSR received funding for this from Pfizer, AbbVie and UCB. These companies receive advance copies of manuscripts for comments but have no input in to the topics for analysis in the register nor the work involved in undertaking analysis. Analysis of data was supported by the Versus Arthritis/Medical Research Council Centre for Musculoskeletal Health and Work [grant number 20665].10279939engSDG 3 - Good Health and Well-beingaxial spondyloarthritisankylosing spondylitisresponsetreatmentanti-TNF-alphabiologic therapyDEPRESSIONSHORT-TERM IMPROVEMENTWORK PRODUCTIVITYRELIABILITYANKYLOSING-SPONDYLITISBATHFIBROMYALGIAINHIBITORSACTIVITY SCORE ASDASBRITISH SOCIETYR Medicine (General)Pharmacology (medical)RheumatologyMedical Research Council (MRC)20665OtherVersus ArthritisR1Journal article10.1093/rheumatology/kez657http://www.scopus.com/inward/record.url?scp=85089454892&partnerID=8YFLogxK599